DVT/VTE
Original Research
Venous Thromboembolism Prophylaxis in Acutely Ill Veterans With Respiratory Disease
This observational study assessed the rate and appropriateness of pharmacologic venous thromboembolism prophylaxis in veterans with pulmonary...
Clinical Review
Trends in Venous Thromboembolism
Case Reports
Pulmonary Vein Thrombosis Associated With Metastatic Carcinoma
Video
The Changing Landscape of VTE Treatment
Watch as Kenneth A. Bauer, MD, discusses the new venous thromboembolism (VTE) oral agents and their impact on the future of care for patients with...
Clinical Review
Prevention of Venous Thromboembolism After Total Joint Replacement: Rivaroxaban Update
Clinical trials have shown that rivaroxaban is superior to enoxaparin, the current standard of care, in preventing venous thromboembolism after...
Article
Silent Pulmonary Embolism: Measuring the Real Risk
Pharmacology
Epoprostenol's Effect on Acute Pulmonary Embolism
Pharmacology
Higher Risk of Venous Thromboembolism with Bevacizumab
Patients with cancer who receive bevacizumab may have a higher risk of venous thromboembolism (VTE) than those not receiving the drug, according...
Clinical Review
The Missed Pulmonary Embolism
Once this condition is suspected, diagnostic efforts must continue until it's confirmed or ruled out absolutely.